Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
GlobeStar Therapeutics Corporation (GSTC) had Income from Continuous Operations of $-1.95M for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-1.95M |
|
-- |
|
-- |
|
$1.86M |
|
$-1.86M |
|
$-0.08M |
|
$-1.95M |
|
$-1.95M |
|
$-1.95M |
|
|
Income from Continuous Operations |
$-1.95M |
$-1.95M |
|
$-1.95M |
|
$-1.86M |
|
$-1.83M |
|
827.33M |
|
827.33M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$1.43M |
|
-- |
|
-- |
|
$1.43M |
|
$-1.44M |
|
$-1.43M |
|
$-1.43M |
|
996.12M |
|
| Cash Flow Statement Financials | |
$-0.21M |
|
-- |
|
$0.20M |
|
$0.01M |
|
$0.00M |
|
$-0.01M |
|
$1.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
135.84% |
|
135.94% |
|
-- |
|
135.94% |
|
$-0.00 |
|
$-0.00 |
|
$-0.00 |
|